Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07089238 · ClinicalTrials.gov registry record · NA
Evaluate the Effects of Citicoline on Mood in Healthy Adults
A NA study of Healthy, sponsored by Kirin Holdings Company, Limited.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT07089238: Recruiting NA study of Healthy, sponsored by Kirin Holdings Company, Limited.
NCT07089238 is a NA study of Healthy that is actively recruiting participants, run by Kirin Holdings Company, Limited. The registered enrollment target is 90 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07089238, a NA study of Healthy, is actively recruiting participants, sponsored by Kirin Holdings Company, Limited.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this trial is to determine the effects of citicoline on mood in healthy Men and Women compared to a placebo.
Primary Outcome
To evaluate the effect of the Test Product (TP) on TMD on the POMS2 compared to a placebo
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Citicoline
Study Locations (1)
Ohio
- The Center for Applied Health Sciences - Canfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-07-31 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT07089238 shows while recruiting
NCT07089238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07089238 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07089238 about?
NCT07089238 is a clinical study titled "Evaluate the Effects of Citicoline on Mood in Healthy Adults". The objective of this trial is to determine the effects of citicoline on mood in healthy Men and Women compared to a placebo.
What is the current status of trial NCT07089238?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-07-31. Estimated completion is 2026-03-31.
What conditions does trial NCT07089238 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT07089238?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Citicoline (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07089238?
This trial is sponsored by Kirin Holdings Company, Limited, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07089238 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07089238's enrollment target sits among peer trials
90 252nd of 1090 higher than 833 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI